
Pubmed-entry ::= {
  pmid 29691439,
  medent {
    em std {
      year 2018,
      month 4,
      day 26,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "Reversal of memory and neuropsychiatric symptoms and reduced tau
 pathology by selenium in 3xTg-AD mice."
      },
      authors {
        names std {
          {
            name ml "Van der Jeugd A",
            affil str "Laboratory of Biological Psychology, Katholieke
 Universiteit Leuven, Leuven, 3000, Belgium."
          },
          {
            name ml "Parra-Damas A",
            affil str "Institut de Neurociencies, Departament de Bioquimica i
 Biologia Molecular, Centro de Investigacion Biomedica en Red Enfermedades
 Neurodegenerativas (CIBERNED), Universitat Autonoma de Barcelona, Bellaterra,
 08193, Spain."
          },
          {
            name ml "Baeta-Corral R",
            affil str "Institut de Neurociencies, Departament de Psiquiatria i
 Medicina Legal, Unitat de Psicologia Medica, Universitat Autonoma de
 Barcelona, Bellaterra, 08193, Spain."
          },
          {
            name ml "Soto-Faguas CM",
            affil str "Institut de Neurociencies, Departament de Bioquimica i
 Biologia Molecular, Centro de Investigacion Biomedica en Red Enfermedades
 Neurodegenerativas (CIBERNED), Universitat Autonoma de Barcelona, Bellaterra,
 08193, Spain."
          },
          {
            name ml "Ahmed T",
            affil str "Laboratory of Biological Psychology, Katholieke
 Universiteit Leuven, Leuven, 3000, Belgium.; Neurological Disorders Research
 Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University,
 Doha, Qatar."
          },
          {
            name ml "LaFerla FM",
            affil str "Department of Neurobiology and Behavior, Institute for
 Memory Impairments and Neurological Disorders, University of California,
 Irvine, 92697, CA, USA."
          },
          {
            name ml "Gimenez-Llort L",
            affil str "Institut de Neurociencies, Departament de Psiquiatria i
 Medicina Legal, Unitat de Psicologia Medica, Universitat Autonoma de
 Barcelona, Bellaterra, 08193, Spain."
          },
          {
            name ml "D'Hooge R",
            affil str "Laboratory of Biological Psychology, Katholieke
 Universiteit Leuven, Leuven, 3000, Belgium."
          },
          {
            name ml "Saura CA",
            affil str "Institut de Neurociencies, Departament de Bioquimica i
 Biologia Molecular, Centro de Investigacion Biomedica en Red Enfermedades
 Neurodegenerativas (CIBERNED), Universitat Autonoma de Barcelona, Bellaterra,
 08193, Spain. carlos.saura@uab.es."
          }
        }
      },
      from journal {
        title {
          iso-jta "Sci Rep",
          ml-jta "Sci Rep",
          issn "2045-2322",
          name "Scientific reports"
        },
        imp {
          date std {
            year 2018,
            month 4,
            day 24
          },
          volume "8",
          issue "1",
          pages "6431",
          language "eng",
          pubstatus epublish,
          history {
            {
              pubstatus received,
              date std {
                year 2018,
                month 1,
                day 25
              }
            },
            {
              pubstatus accepted,
              date std {
                year 2018,
                month 4,
                day 5
              }
            },
            {
              pubstatus other,
              date std {
                year 2018,
                month 4,
                day 26,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2018,
                month 4,
                day 25,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2019,
                month 10,
                day 30,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 29691439,
        doi "10.1038/s41598-018-24741-0",
        pii "10.1038/s41598-018-24741-0",
        other {
          db "pmc",
          tag str "PMC5915484"
        },
        other {
          db "ELocationID doi",
          tag str "10.1038/s41598-018-24741-0"
        }
      }
    },
    abstract "Accumulation of amyloid-beta plaques and tau contribute to the
 pathogenesis of Alzheimer's disease (AD), but it is unclear whether targeting
 tau pathology by antioxidants independently of amyloid-beta causes beneficial
 effects on memory and neuropsychiatric symptoms. Selenium, an essential
 antioxidant element reduced in the aging brain, prevents development of
 neuropathology in AD transgenic mice at early disease stages. The therapeutic
 potential of selenium for ameliorating or reversing neuropsychiatric and
 cognitive behavioral symptoms at late AD stages is largely unknown. Here, we
 evaluated the effects of chronic dietary sodium selenate supplementation for
 4 months in female 3xTg-AD mice at 12-14 months of age. Chronic sodium
 selenate treatment efficiently reversed hippocampal-dependent learning and
 memory impairments, and behavior- and neuropsychiatric-like symptoms in old
 female 3xTg-AD mice. Selenium significantly decreased the number of
 aggregated tau-positive neurons and astrogliosis, without globally affecting
 amyloid plaques, in the hippocampus of 3xTg-AD mice. These results indicate
 that selenium treatment reverses AD-like memory and neuropsychiatric symptoms
 by a mechanism involving reduction of aggregated tau and/or reactive
 astrocytes but not amyloid pathology. These results suggest that sodium
 selenate could be part of a combined therapeutic approach for the treatment
 of memory and neuropsychiatric symptoms in advanced AD stages.",
    mesh {
      {
        term "Alzheimer Disease",
        qual {
          {
            subh "metabolism"
          },
          {
            subh "pathology"
          }
        }
      },
      {
        term "Amyloid beta-Peptides",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Amyloid beta-Protein Precursor",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Animals"
      },
      {
        term "Brain",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Dietary Supplements"
      },
      {
        term "Disease Models, Animal"
      },
      {
        term "Female"
      },
      {
        term "Hippocampus",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Humans"
      },
      {
        term "Maze Learning",
        qual {
          {
            subh "drug effects"
          }
        }
      },
      {
        term "Memory",
        qual {
          {
            mp TRUE,
            subh "drug effects"
          }
        }
      },
      {
        term "Memory Disorders",
        qual {
          {
            subh "pathology"
          }
        }
      },
      {
        term "Mice"
      },
      {
        term "Mice, Inbred C57BL"
      },
      {
        term "Mice, Transgenic"
      },
      {
        term "Neurons",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Plaque, Amyloid",
        qual {
          {
            subh "pathology"
          }
        }
      },
      {
        term "Presenilin-1",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Selenic Acid",
        qual {
          {
            subh "metabolism"
          },
          {
            mp TRUE,
            subh "pharmacology"
          }
        }
      },
      {
        term "Selenium",
        qual {
          {
            subh "metabolism"
          },
          {
            subh "pharmacology"
          }
        }
      },
      {
        term "tau Proteins",
        qual {
          {
            mp TRUE,
            subh "drug effects"
          },
          {
            subh "metabolism"
          }
        }
      }
    },
    substance {
      {
        type nameonly,
        name "Amyloid beta-Peptides"
      },
      {
        type nameonly,
        name "Amyloid beta-Protein Precursor"
      },
      {
        type nameonly,
        name "Presenilin-1"
      },
      {
        type nameonly,
        name "tau Proteins"
      },
      {
        type cas,
        cit "H6241UJ22B",
        name "Selenium"
      },
      {
        type cas,
        cit "HV0Y51NC4J",
        name "Selenic Acid"
      }
    },
    pmid 29691439,
    pub-type {
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    },
    status medline
  }
}


